恒邦股份(002237) - 2020 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2020 was ¥6,384,824,595.03, representing a 9.04% increase compared to ¥5,855,543,210.33 in the same period last year[7]. - The net profit attributable to shareholders of the listed company decreased by 17.99% to ¥89,367,678.17 from ¥108,970,404.04 year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥288,740,670.58, a decline of 341.60% compared to ¥119,511,247.30 in the previous year[7]. - The basic earnings per share decreased by 16.67% to ¥0.10 from ¥0.12 in the same period last year[7]. - The diluted earnings per share also decreased by 16.67% to ¥0.10 from ¥0.12 year-on-year[7]. - The total profit for the current period was ¥105,899,878.40, a decrease of 16.5% from ¥126,847,845.90 in the previous period[60]. - The company's net profit attributable to the parent company was ¥89,367,678.17, down 18.1% from ¥108,970,404.04 in the previous period[60]. - The total comprehensive income for the current period was ¥88,162,037.27, slightly down from ¥89,503,116.50 in the previous period[64]. Cash Flow - The net cash flow from operating activities was ¥259,556,904.27, down 23.29% from ¥338,373,788.28 in the same period last year[7]. - The company reported a net cash inflow from operating activities of ¥7,302,005,061.79, up from ¥5,980,670,427.52 in the previous period[72]. - Operating cash inflow totaled CNY 7,649,495,616.89, an increase from CNY 5,173,935,722.79 in the previous period[81]. - Net cash flow from operating activities was CNY 236,779,736.48, down from CNY 283,684,376.38 year-over-year[81]. - The net increase in cash and cash equivalents was CNY 573,019,064.32, compared to CNY 117,221,129.13 in the previous period[84]. - The ending balance of cash and cash equivalents was CNY 842,271,001.54, up from CNY 319,423,142.31 last year[84]. Assets and Liabilities - The total assets at the end of the reporting period were ¥18,001,909,775.82, an increase of 11.53% from ¥16,140,794,194.52 at the end of the previous year[7]. - The total current assets as of March 31, 2020, amounted to approximately ¥12.80 billion, an increase from ¥10.84 billion as of December 31, 2019[39]. - Total assets increased to ¥17,562,492,528.42 from ¥15,887,047,835.61, reflecting a growth of 10.56%[54]. - Total liabilities increased to approximately ¥13.26 billion from ¥11.49 billion at the end of 2019[44]. - Total liabilities rose to ¥12,730,413,216.96, up from ¥11,151,648,321.80, marking an increase of 14.16%[54]. - The total amount of accounts payable was ¥1,898,997,309.96, which is a critical component of the company's liabilities[87]. - The company has a deferred income tax asset of ¥64,026,601.09, which may impact future tax liabilities[87]. Equity and Shareholder Information - The net assets attributable to shareholders of the listed company increased by 2.01% to ¥4,751,726,720.00 from ¥4,658,175,632.22 at the end of the previous year[7]. - The company's equity attributable to shareholders increased to ¥4,832,079,311.46 from ¥4,735,399,513.81, a growth of 2.05%[54]. - The total equity attributable to the parent company was ¥4,658,175,632.22, showcasing the company's financial health[89]. Operational Metrics - Operating costs for the quarter were ¥6,549,348,028.23, up from ¥5,716,352,705.02, an increase of 14.59%[58]. - Research and development expenses decreased to ¥2,640,217.13 from ¥2,906,954.00, a reduction of 9.14%[58]. - The company reported a net investment income of ¥335,800,138.50, compared to a loss of ¥12,940,834.14 in the previous year[58]. - The company recorded an investment income of ¥333,559,119.94, a significant recovery from a loss of ¥13,634,260.08 in the previous period[65]. Government Support and Compliance - The company received government subsidies amounting to ¥6,442,269.26 during the reporting period, primarily related to revenue[7]. - The company reported no significant non-compliance issues or overdue commitments from major shareholders during the reporting period[27].